FDA Inspection
Biogenesis, IncBiogenesis, Inc – FDA Inspection, Nov 18, 2014
Record Details
This FDA Inspection record concerns Biogenesis, Inc, with an inspection on November 18, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Biogenesis, Inc
- Inspection Date
- November 18, 2014
- Product Type
- Drugs
View Company Profile
ID · 4ea78634-c3a1-4665-b55b-06382f2dd5ef
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 904579
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.101(b)Identification of new containers
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biogenesis, Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 27, 2025 | VAI | New Jersey District Office | Drug Quality Assurance |
| January 17, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 2, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 5, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Biogenesis, Inc
- FDA Inspection 1260213 - 2025-02-27
- FDA Inspection 1116511 - 2020-01-17
- FDA Inspection 765724 - 2012-02-02
- FDA Inspection 669967 - 2010-08-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.